Therapeutic Window

Therapeutic Window designates the range of drug exposures or doses where therapeutic benefits occur without unacceptable toxicity, representing practical boundaries for safe and effective treatment. This concept integrates pharmacokinetics, pharmacodynamics, patient variability, and disease factors, with narrow therapeutic windows requiring careful dosing, monitoring, and management to maintain drug concentrations within safe limits.

The pharmaceutical industry defines therapeutic windows during clinical development by analysing dose-response relationships for both efficacy and adverse events. Exposure-response modelling identifies concentration ranges associated with optimal outcomes, guiding dose selection and labelling. Drugs with narrow therapeutic windows require additional safeguards including therapeutic drug monitoring, dose titration protocols, and warnings for drug-drug interactions or organ impairment. Clinical trial design may incorporate adaptive dosing strategies and pharmacodynamic biomarkers ensuring patients remain within effective ranges. Regulatory authorities evaluate therapeutic windows when assessing benefit-risk profiles and determining risk management requirements. As precision dosing approaches advance through pharmacogenomics and modelling, defining and maintaining therapeutic windows continues supporting safer therapeutic use while optimising clinical outcomes across diverse patient populations.